Drug Type Chemical drugs |
Synonyms Pixatimod, PG500 program |
Target |
Action inhibitors |
Mechanism Heparanase inhibitors, Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC51H88NaO60S13 |
InChIKeyRPAUSRYLSBRVEA-PLSSCWMPSA-N |
CAS Registry1144492-69-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 2 | United States | 14 Nov 2021 | |
Melanoma | Phase 2 | United States | 24 Oct 2021 | |
Colorectal Cancer | Phase 2 | United States | 10 Oct 2021 | |
Pancreatic Cancer | Phase 1 | Australia | - | 23 Oct 2017 |
Advanced Malignant Solid Neoplasm | Phase 1 | Australia | 01 Jan 2011 | |
Ovarian Cancer | Preclinical | United States | 22 Mar 2021 | |
Breast Cancer | Preclinical | Australia | - | |
Liver Cancer | Preclinical | - | - |
Phase 1 | Solid tumor | Metastatic Microsatellite Stable Colorectal Carcinoma | Metastatic Pancreatic Ductal Adenocarcinoma Pan-Immune-Inflammation Value | plasma IL-6 | IP-10 ... View more | - | abvdjdkwne(xmisbxdjzz) = Twenty-one grade 3-5 treatment-related adverse events were reported in 12 participants (21%); one participant receiving 50 mg pixatimod/nivolumab had a treatment-related grade 5 AE vspznsggex (copmxtodty ) | Positive | 01 Jan 2023 | ||
Phase 1 | Pancreatic adenocarcinoma metastatic | Advanced Malignant Solid Neoplasm CA19.9 | interleukins (IL) IL-1α | IL-23 | 16 | utnmqqxwab(jicdzndkpv) = nmcrxijrcv nlrtmjcoro (kmovhoqfpi ) | Negative | 10 Nov 2021 | ||
utnmqqxwab(jicdzndkpv) = ztsvzxnpjm nlrtmjcoro (kmovhoqfpi ) | |||||||
Phase 1 | 23 | wosyywkeiz(vjileqeuse) = ubpegnxjcu iimkhxcrnx (ndwjrbkvxs ) View more | - | 30 May 2017 | |||
Phase 1 | 4 | (25 mg Dose) | tyygcortns = atjrqbmcjk hwqdvdqsva (dezkzndlxp, tfnuqpawmb - timmogbewk) View more | - | 02 Aug 2012 | ||
(50 mg Dose) | tyygcortns = tmgzumjspg hwqdvdqsva (dezkzndlxp, pufyootlok - wwpeqyvhem) View more |